Your browser doesn't support javascript.
loading
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.
Schubert, Klaus Oliver; Thalamuthu, Anbupalam; Amare, Azmeraw T; Frank, Joseph; Streit, Fabian; Adl, Mazda; Akula, Nirmala; Akiyama, Kazufumi; Ardau, Raffaella; Arias, Bárbara; Aubry, Jean-Michel; Backlund, Lena; Bhattacharjee, Abesh Kumar; Bellivier, Frank; Benabarre, Antonio; Bengesser, Susanne; Biernacka, Joanna M; Birner, Armin; Marie-Claire, Cynthia; Cearns, Micah; Cervantes, Pablo; Chen, Hsi-Chung; Chillotti, Caterina; Cichon, Sven; Clark, Scott R; Cruceanu, Cristiana; Czerski, Piotr M; Dalkner, Nina; Dayer, Alexandre; Degenhardt, Franziska; Del Zompo, Maria; DePaulo, J Raymond; Étain, Bruno; Falkai, Peter; Forstner, Andreas J; Frisen, Louise; Frye, Mark A; Fullerton, Janice M; Gard, Sébastien; Garnham, Julie S; Goes, Fernando S; Grigoroiu-Serbanescu, Maria; Grof, Paul; Hashimoto, Ryota; Hauser, Joanna; Heilbronner, Urs; Herms, Stefan; Hoffmann, Per; Hou, Liping; Hsu, Yi-Hsiang.
Afiliação
  • Schubert KO; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Thalamuthu A; Northern Adelaide Local Health Network, Mental Health Services, Adelaide, SA, Australia.
  • Amare AT; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.
  • Frank J; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Streit F; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Adl M; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Akula N; Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.
  • Akiyama K; Intramural Research Program, National Institute of Mental Health, National Institutes of Health, US Department of Health & Human Services, Bethesda, MD, USA.
  • Ardau R; Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
  • Arias B; Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
  • Aubry JM; Unitat de Zoologia i Antropologia Biològica (Dpt. Biologia Evolutiva, Ecologia i Ciències Ambientals), Facultat de Biologia and Institut de Biomedicina (IBUB), University of Barcelona, CIBERSAM, Barcelona, Spain.
  • Backlund L; Department of Psychiatry, Mood Disorders Unit, HUG-Geneva University Hospitals, Geneva, Switzerland.
  • Bhattacharjee AK; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Bellivier F; Department of Psychiatry, University of California San Diego, San Diego, CA, USA.
  • Benabarre A; INSERM UMR-S 1144, Université Paris Diderot, Département de Psychiatrie et de Médecine Addictologique, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-F.Widal, Paris, France.
  • Bengesser S; Bipolar Disorder Program, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.
  • Biernacka JM; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for bipolar affective disorder, Medical University of Graz, Graz, Austria.
  • Birner A; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Marie-Claire C; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for bipolar affective disorder, Medical University of Graz, Graz, Austria.
  • Cearns M; INSERM UMR-S 1144, Université Paris Diderot, Département de Psychiatrie et de Médecine Addictologique, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-F.Widal, Paris, France.
  • Cervantes P; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Chen HC; The Neuromodulation Unit, McGill University Health Centre, Montreal, QC, Canada.
  • Chillotti C; Department of Psychiatry & Center of Sleep Disorders, National Taiwan University Hospital, Taipei, Taiwan.
  • Cichon S; Unit of Clinical Pharmacology, Hospital University Agency of Cagliari, Cagliari, Italy.
  • Clark SR; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Cruceanu C; Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Czerski PM; Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Dalkner N; Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
  • Dayer A; Psychiatric Genetic Unit, Poznan University of Medical Sciences, Poznan, Poland.
  • Degenhardt F; Department of Psychiatry and Psychotherapeutic Medicine, Research Unit for bipolar affective disorder, Medical University of Graz, Graz, Austria.
  • Del Zompo M; Department of Psychiatry, Mood Disorders Unit, HUG-Geneva University Hospitals, Geneva, Switzerland.
  • DePaulo JR; Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Étain B; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
  • Falkai P; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
  • Forstner AJ; INSERM UMR-S 1144, Université Paris Diderot, Département de Psychiatrie et de Médecine Addictologique, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-F.Widal, Paris, France.
  • Frisen L; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany.
  • Frye MA; Human Genomics Research Group, Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Fullerton JM; Institute of Human Genetics, University of Bonn and Department of Genomics, Life & Brain Center, Bonn, Germany.
  • Gard S; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Garnham JS; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Goes FS; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Grigoroiu-Serbanescu M; Neuroscience Research Australia, Sydney, NSW, Australia.
  • Grof P; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Hashimoto R; Service de psychiatrie, Hôpital Charles Perrens, Bordeaux, France.
  • Hauser J; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Heilbronner U; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MD, USA.
  • Herms S; Biometric Psychiatric Genetics Research Unit, Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania.
  • Hoffmann P; Mood Disorders Center of Ottawa, Ottawa, ON, Canada.
  • Hou L; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan.
  • Hsu YH; Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
Transl Psychiatry ; 12(1): 278, 2022 Jul 11.
Article em En | MEDLINE | ID: mdl-35817769

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
...